Hyperinsulinemia in Prediabetes Mediated by Interleukin-1β
Clinical trial NCT05854251 · COMPLETED
Trial details
- NCT number
- NCT05854251
- Sponsor
- University Hospital, Basel, Switzerland
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-15
- Primary completion
- 2024-05-17
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.